... CA:Clinical dose-volume histogram analysis for pneumonitis after 3Dtreatment for non- smallcelllungcancer (NSCLC). Int J Radiat Oncol BiolPhys 199 9, 45:323-3 29. 25. Kwa SL, Lebesque JV, Theuws JC, ... Oncol Biol Phys 2002, 52:382-3 89. 16. Qiao X, Tullgren O, Lax I, Sirzén F, Lewensohn R: The role of radiotherapyin treatment of stage I non- smallcelllung cancer. LungCancer 2003,41:1-11.17. ... M, Hara R, Itami J, Yamada K, Araki T: Hypofractionatedstereotactic radiotherapy (HypoFXSRT) for stage I non- smallcell lung cancer: updated results of 257 patients in a Japanese multi-institutionalstudy....
... 2004, 59: 960 -97 0. 9. Kupelian PA, Ramsey C, Meeks SL, Willough TR, Forbes A, WagnerTH, Langen KM: Serial megavoltage CT imaging during exter-nal beam radiotherapy for non- small- celllung cancer: ... AbstractBackground: To evaluate the performance of surface-based deformable image registration (DR) for adaptive radiotherapy of non- smallcelllungcancer (NSCLC).Methods: Based on 13 patients ... evaluation of deformable image registrationComparison of CTplan and CTdeform was performed for evaluation of the DR. Based on ROIextended, DR improvedthe CC for images acquired mid-way of the...
... review of nonsurgical treatment options for stage I non- smallcelllung cancer. Oncologist 2008, 13:3 09- 3 19. 41. Brock J, Ashley S, Bedford J, Nioutsikou E, Partridge M, Brada M:Review of Hypofractionated ... body radiotherapy for stage I non- smallcelllung cancer. Radiother Oncol 2007, 85:4 29- 434. 39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana ... influence of dif-ferent planning algorithms on the planning of stereotacticradiotherapy. Therefore, an additional planning study wasperformed in 22 stage IA and 4 stage 1B non- small cell lung cancer...
... 2 of 6(page number not for citation purposes)BackgroundThe use of accelerated hypofractionated radiation therapyis an attractive option for patients with early stage non- small celllungcancer ... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patients with medically inoperable, early stage, non- smallcell lung cancer ... 1 of 6(page number not for citation purposes)Radiation OncologyOpen AccessResearchAbsence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non- small...
... sensitivity of 95 .2%and a specificity of 98 .8% for L858R. Kitamura et al [22]reported a s ensitivity of 36% and a specificity of 97 % for L858R and a sensitivity of 40% and a specificity of 99 % for ... sensitivityoverall 92 %delE746-A750 Ab 63% 22.86% 81.1% 99 % 84.6% 79% l858r Ab 100% 75% 97 % 95 .2% 83%IHC specificityoverall 99 %delE746-A750 Ab 100% 92 % 100% 40% 98 .8%L858R Ab 100% 96 .6% 36% 98 .8%Simonetti ... Non- small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80. 9. Gazdar AF: Activating and resistance mutations of EGFR in non- small- cell lung cancer: ...
... aftercomplete resection of non- smallcelllung carcinoma. Cancer Res 2010,70:8288 -98 . 19. Goldstraw P:The 7th Edition of TNM in Lung Cancer: what now? J ThoracOncol 20 09, 4:671-3.20. Sandler ... marker expression in tumor cells versus stromal cells in non smallcelllung cancer. Clin Cancer Res 2007, 13:66 49- 57.24. World Health Organization: Histological Typing ofLung and PleuralTumours. ... compartment in non- small- cell lung cancer. Br J Cancer 2008, 99 :1476-83.27. Al-Saad S, Donnem T, Al-Shibli K, Persson M, Bremnes RM, Busund LT:Diverse prognostic roles of Akt isoforms, PTEN and...
... (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non- small- cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 199 8, 42(3):4 69- 78. 29. Claude ... influence of age on the delivery, tolerance, an efficacy of thoracic irradiation in the combined modality treatment of limited stage smallcelllung cancer. Int J Radiat Oncol Biol Phys 199 9, 43: 39- 45.31. ... Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non- smallcelllungcancer (NSCLC). Int J Radiat Oncol Biol Phys 199 9, 45:323-3 29. 15. Tsujino K, Hirota S, Endo M,...
... Stereotactic Body Rad iotherapy, Oligometastases, Non- SmallCellLung Cancer Background Non- smallcelllungcancer (NSCLC) is the leadingcause ofcancer mortality in the United States [1].Patients ... Milano1*AbstractBackground: Standard therapy for metastatic nonsmallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies of patients with limited metastases ... 6:80http://www.ro-journal.com/content/6/1/80Page 2 of 7 RESEARC H Open AccessComparison of outcomes in patients with stage IIIversus limited stage IV non- smallcelllung cancer Praveena Cheruvu1, Su K Metcalfe1,...
... inStage III non- smallcelllung cancer? An analysis of recur-rences in a phase II study of induction chemotherapy andinvolved-field radiotherapy. Int J Radiat Oncol Biol Phys 2002,54(4) :99 9-1006.10. ... distribution of occult micrometas-tases in lymph nodes of patients with non- small- celllung car-cinoma. J Natl Cancer Inst 199 3, 85: 493 - 498 .17. Herth FJ, Eberhardt R, Krasnik M, Ernst A: Endobronchial ... Incidental dose to clinicallynegative nodes from conformal treatment fields for nons-mall celllung cancer. Int J Radiat Oncol Biol Phys 199 9, 45:S244.13. Klopp AH, Chang JY, Tucker SL, Sulman...
... http://www.ro-journal.com/content/1/1/30Page 9of 9 (page number not for citation purposes)inoperable non- smallcelllungcancer without mediastinalinvolvement (clinical stage N0, N1). Strahlenther Onkol 199 6,172:4 89- 495 .22. ... N, Saito Y, et al.: Limited field irradiation for medically inoperable patients with peripheral stage I non- smallcelllung cancer. LungCancer 199 9, 26:137-142.23. Slotman BJ, Antonisse IE, ... CentralPage 1 of 9 (page number not for citation purposes)Radiation OncologyOpen AccessResearchStereotactic, single-dose irradiation of stage I non- smallcelllung cancer and lung metastasesPeter...